Stock Price
1,520.60
Daily Change
18.95 1.26%
Monthly
11.18%
Yearly
26.08%
Q2 Forecast
1,478.96

Aurobindo Pharma reported INR73.37B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Cipla INR 59.27B 1.71B Mar/2026
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Dr.Reddys Laboratories INR 74.58B 977M Mar/2026
Hindustan Unilever INR 128.58B 1.32B Mar/2026
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
UPL INR 156.03B 49.4B Mar/2026